BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan

Familial Cancer

Volumn 13, Issue 3, 2014, Pages 437-444

  Biunno, Ida ^a,b   Aceto, Gitana ^c   Awadelkarim, Khalid Dafaallah ^d   Morgano, Annalisa ^c   Elhaj, Ahmed ^d   Eltayeb, Elgaylani Abdalla ^d   Abuidris, Dafalla Omer ^d   Elwali, Nasr Eldin ^e   Spinelli, Chiara ^f   De Blasio, Pasquale ^f   Rovida, Ermanna ^a   Mariani Costantini, Renato ^c  

^a Milan Unit   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF GEZIRA   (Sudan)

^e AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

^f Integrated Systems Engineering srl   (Italy)

Author keywords

Africa; BRCA1; Breast cancer; Germline mutations; Premenopausal; Sudan

Indexed keywords

BRCA1 PROTEIN;

ADULT; AFRICA; AFRICAN; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; COMPUTER MODEL; CONFORMATIONAL TRANSITION; DISEASE PREDISPOSITION; EXON; FEMALE; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; GERMLINE MUTATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR RECOGNITION; POINT MUTATION; PREMENOPAUSE; PROTEIN CONFORMATION; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; STEREOSPECIFICITY; STOP CODON; SUDAN; SUDANESE; TANDEM REPEAT; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; AMINO ACID SEQUENCE; BREAST TUMOR; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN QUATERNARY STRUCTURE; YOUNG ADULT;

ADULT; AMINO ACID SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PROTEIN STRUCTURE, QUATERNARY; SUDAN; YOUNG ADULT;

EID: 84907172283     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-014-9717-4     Document Type: Article

References (52)

1. Pagani F, Baralle FE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5(5):389-396
2. Plon SE, Eccles DM, Easton D et al (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29(11):1282-1291
3. Lee MS, Green R, Marsillac SM et al (2010) Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Res 70(12):4880-4890
4. Walker LC, Whiley PJ, Couch FJ et al (2010) Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity. Hum Mutat 31(6):E1484-E1505
5. Williams RS, Glover JN (2003) Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. J Biol Chem 278(4):2630-2635
6. Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, Tavtigian SV (2006) Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res 34(5):1317-1325
7. Karchin R, Monteiro AN, Tavtigian SV, Carvalho MA, Sali A (2007) Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput Biol 3(2):e26
8. Quiles F, Fernandez-Rodriguez J, Mosca R et al (2013) Functional and structural analysis of C-terminal BRCA1 missense variants. PLoS ONE 8(4):e61302
9. Thery JC, Krieger S, Gaildrat P et al (2011) Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet 19(10):1052-1058
10. Coquelle N, Green R, Glover JN (2011) Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition. Biochemistry 50(21):4579-4589
11. Greenberg RA (2011) Cancer. BRCA1, everything but the RING? Science 334(6055):459-460
12. Campbell MC, Tishkoff SA (2008) African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomic Hum Genet 9:403-433
13. Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C (2003) Breast cancer genetics in African Americans. Cancer 97(1 Suppl):236-245
14. Oluwagbemiga LA, Oluwole A, Kayode AA (2012) Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review. Springerplus 1(1):83
15. Fackenthal JD, Zhang J, Zhang B et al (2012) High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. Int J Cancer 131(5):1114-1123
16. Mariani-Costantini R (2013) Diagnosis: breast cancer screening in rural African communities. Nat Rev Clin Oncol 10(4):185-186
17. Awadelkarim KD, Elhaj A, Aceto G, Mariani-Costantini R, Eltayeb EA (2012) Hereditary breast cancer in Sub-Saharan Africa. Curr Women's Health Rev 8(1):44-54
18. Awadelkarim KD, Arizzi C, Elamin EO et al (2008) Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 52(4):445-456
19. Awadelkarim KD, Mariani-Costantini R, Elwali NE (2012) Cancer in the Sudan: an overview of the current status of knowledge on tumor patterns and risk factors. Sci Total Environ 9(423):214-228
20. Awadelkarim KD, Aceto G, Veschi S et al (2007) BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 102(2):189-199
21. Malferrari G, Monferini E, DeBlasio P et al (2002) High-quality genomic DNA from human whole blood and mononuclear cells. Biotechniques 33(6):1228-1230
22. Gross E, Arnold N, Pfeifer K, Bandick K, Kiechle M (2000) Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 16(4):345-353
23. Judkins T, Rosenthal E, Arnell C et al (2012) Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 118(21):5210-5216
24. Zhang J, Fackenthal JD, Huo D, Zheng Y, Olopade OI (2010) Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population. Breast Cancer Res Treat 124(2):573-577
25. Lindor NM, Guidugli L, Wang X et al (2011) A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat 33(1):8-21
26. Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A (2008) Classification of rare missense substitutions, using risk surfaces, with genetic-and molecular-epidemiology applications. Hum Mutat 29(11):1342-1354
27. Altshuler DM, Gibbs RA, Peltonen L et al (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467(7311):52-58
28. Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43(4):295-305
29. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30(17):3894-3900
30. Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248-249
31. Ng PC, Henikoff S (2002) Accounting for human polymorphisms predicted to affect protein function. Genome Res 12(3):436-446
32. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37(9):e67
33. Williams RS, Green R, Glover JN (2001) Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat Struct Biol 8(10):838-842
34. Berman H, Henrick K, Nakamura H (2003) Announcing the worldwide protein data bank. Nat Struct Biol 10(12):980
35. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234(3):779-815
36. Fiser A, Do RK, Sali A (2000) Modeling of loops in protein structures. Protein Sci 9(9):1753-1773
37. Guerois R, Nielsen JE, Serrano L (2002) Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 320(2):369-387
38. el El-Harith HA, Abdel-Hadi MS, Steinmann D, Dork T (2002) BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi Med J 23(6):700-704
39. Chen X, Truong TT, Weaver J et al (2006) Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat 27(5):427-435
40. Scholl T, Pyne MT, Russo D, Ward BE (1999) BRCA1 IVS16+6T->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site. Am J Med Genet 85(2):113-116
41. Judkins T, Hendrickson BC, Deffenbaugh AM, Scholl T (2005) Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mutat Res 573(1-2):168-179
42. Spurdle AB, Lakhani SR, Healey S et al (2008) Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis-a report from the kConFab Investigators. J Clin Oncol 26(10):1657-1663
43. Needham CJ, Bradford JR, Bulpitt AJ, Care MA, Westhead DR (2006) Predicting the effect of missense mutations on protein function: analysis with Bayesian networks. BMC Bioinform 7:405
44. Cantor SB, Bell DW, Ganesan S et al (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105(1):149-160
45. Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R (1998) The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem 273(39):25388-25392
46. Chapman MS, Verma IM (1996) Transcriptional activation by BRCA1. Nature 382(6593):678-679
47. Monteiro AN, August A, Hanafusa H (1996) Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 93(24):13595-13599
48. Clapperton JA, Manke IA, Lowery DM et al (2004) Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat Struct Mol Biol 11(6):512-518
49. Masso M, Vaisman II (2010) AUTO-MUTE: web-based tools for predicting stability changes in proteins due to single amino acid replacements. Protein Eng Des Sel 23(8):683-687
50. Parthiban V, Gromiha MM, Schomburg D (2006) CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Res 34(Web Server issue):W239-W242
51. Vallon-Christersson J, Cayanan C, Haraldsson K et al (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10(4):353-360
52. Nomine Y, Botuyan MV, Bajzer Z et al (2008) Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations. Biochemistry 47(37):9866-9879